Navigation Links
Scientists uncover key piece to cancer cell survival puzzle
Date:8/7/2014

A chance meeting between two leading UK and US scientists could have finally helped solve a key mystery in cancer research.

Scientists have long known that chromosomal defects occur as cells repeatedly divide. Over time, these defects are linked to the onset of cancer.

Now, Professor Duncan Baird and his team from Cardiff University working in collaboration with Eric A. Hendrickson from the University of Minnesota, have identified a specific gene that human cells require in order to survive these types of defects.

"We have found a gene that appears to be crucial for the evolutionary processes that can drive cancer" said Professor Baird from Cardiff University's Institute of Cancer and Genetics.

"This is a new role for this gene, making it a potential therapeutic target," he added.

As cells divide their telomeres the DNA "caps" that protect the ends of chromosomes from damage shorten, leaving the chromosomes vulnerable to sticking to each other.

In normal cells, this chromosome stickiness is a death knell a signal to trigger the defective-cell clean-up process to move in and help finish them off.

Malignant cells, however, are somehow able to elude this clean-up process.

The current research, published in journal Cell Reports, identifies an essential component that allows older cells to evade death.

Using sophisticated gene-targeting techniques to disable particular genes in human cells and then studying the impact on telomere fusion, the researchers found that cells escaped death only when the gene Ligase 3 was active but not when its action, which appears to promote fusion within like chromosomes rather than between different chromosomes, was blocked.

"Telomere dysfunction has been identified in many human cancers, and as we have shown previously, short telomeres can predict the outcome of patients with [chronic lymphocytic leukemia] and probably many other tumor types," according to Professor Baird.

"Thus, the discovery that Ligase 3 is required for this process is fundamentally important," he adds.

Interestingly, the research was made possible by a chance meeting between Cardiff's Professor Baird and Professor Eric Hendrickson from the University of Minnesota at an international conference.

The pair quickly discovered they were both looking at the role of Ligase 3 in cancer, they decided to collaborate.

"The collaboration paid off as we were able to uncover something that neither one of us could have done on our own," Professor Hendrickson says.

Importantly, additional studies are already underway. In particular, the reliance on Ligase 3 appears, in turn, to be dependent upon the activity of another key DNA repair gene, p53.

"Since p53 is the most commonly mutated gene in human cancer, it now behooves us to discover how these two genes are interacting and to see if we can't use that information to develop synergistic treatment modalities," added Professor Hendrickson.


'/>"/>
Contact: Chris Jones
jonesc83@cardiff.ac.uk
029-208-74731
Cardiff University
Source:Eurekalert

Related medicine news :

1. Sharp Rise in Risk With New Breast Cancer Gene, Scientists Say
2. Aspirin: Scientists believe cancer prevention benefits outweigh harms
3. Scientists Shed Light on Link Between Depression, Dementia
4. Scientists pinpoint bladder cancer patients who could benefit from tumor-softening treatment
5. Scientists to study hereditary breast cancer to find BRCA1 treatment
6. Drexel Scientists Develop Compound to Stop Spread of Metastatic Cancer Cells
7. Scientists test nanoparticle alarm clock to awaken immune systems put to sleep by cancer
8. Brain Tumor Causes and Risk Factors Elude Scientists
9. Brain tumor causes and risk factors elude scientists
10. Mount Sinai Scientists and International Team Shed New Light on Schizophrenia in Largest Genomic Study Published to Date
11. NIH-supported scientists demonstrate very early formation of SIV reservoir
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... May 26, 2016 , ... Despite last week’s media reports hinting at ... company to wait until March 2017 for an interest rate increase, according to Rajeev ... of Business. , “The Federal Open Market Committee (FOMC) dot charts are of interest ...
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... with discovery of thousands of defective respirators, according to court documents and SEC ... case of William and Becky Tyler v. American Optical Corporation, Case No. BC588866, ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, ... as a partner for the Tamika Catchings Legacy Tour that will commemorate ... leader in hardwood basketball surfaces in all forms and levels of the game, Connor ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... a significant negative impact on long-term patient survival, reports a team of UPMC ... online this week in the Journal of Thoracic and Cardiovascular Surgery, provide critical ...
(Date:5/26/2016)... ... May 26, 2016 , ... Catalent Pharma Solutions, the ... consumer health and global clinical supply services, today announced two key appointments and ... continued investment and strategic growth plans in the Asia Pacific region. , Howard ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , Germany and ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime ... a licensing and co-development agreement with Therawis Diagnostics GmbH to ... will be to develop and market PITX2 as a marker ... other high-risk breast cancer patients. "We are pleased ...
(Date:5/25/2016)... 25, 2016 As illustrated by ... this month, the numbers and momentum of cannabis in ... into the billions, more research and development push the ... State of Legal Marijuana Markets Report  from from ArcView ... much of the increase in sector is attributed to ...
(Date:5/25/2016)... , May 25, 2016 ... the precision of circulating tumour DNA (ctDNA) analysis ... the appointment of Professor Clive Morris ... leadership across the clinical development programme, scientific collaborations, ... help deliver significant improvements in clinical outcomes for ...
Breaking Medicine Technology: